Literature DB >> 9577378

A renin secreting ovarian steroid cell tumour associated with secondary polycythaemia.

M R Stephen1, G B Lindop.   

Abstract

A 67-year-old woman presented with dry skin, facial hair, hoarse voice, and weight gain. She was hypertensive (168/ 96 mm Hg), her haemoglobin concentration was 19 g/l, and haematocrit was 55.7%. The diagnosis of probable secondary polycythaemia was made. Blood testosterone concentration was 44 nmol/l (normal < 5) and was not suppressed by dexamethasone, suggesting a neoplastic source rather than a pituitary abnormality. Transvaginal ultrasound revealed a hypoechoic solid mass in the left ovary suggestive of a solid ovarian tumour. Hysterectomy and bilateral salpingo-oophorectomy were performed following which testosterone concentration returned to normal. Immunocytochemistry provided evidence of renin synthesis. This is a case of an unusual steroid cell tumour that caused virilisation accompanied by symptoms of secondary polycythaemia presumably as a result of erythropoietin production. This is the second case of a steroid cell tumour with an erythropoietic effect and the first that shows evidence of renin synthesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577378      PMCID: PMC500437          DOI: 10.1136/jcp.51.1.75

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  8 in total

1.  Ovarian steroid cell tumors (not otherwise specified). A clinicopathological analysis of 63 cases.

Authors:  M C Hayes; R E Scully
Journal:  Am J Surg Pathol       Date:  1987-11       Impact factor: 6.394

2.  Immunohistochemical localization of inhibin/activin subunits in human ovarian follicles during the menstrual cycle.

Authors:  M Yamoto; S Minami; R Nakano; M Kobayashi
Journal:  J Clin Endocrinol Metab       Date:  1992-05       Impact factor: 5.958

3.  Ectopic ACTH syndrome due to bilateral ovarian androblastoma with double, gynandroblastic differentiation in one ovary.

Authors:  A A Kasperlik-Zaluska; L Sikorowa; E Ploch; P Soszyński; W Jeske; B Migdalska; M Wysocki
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1993-12-30       Impact factor: 2.435

4.  Demonstration of renin gene expression in nephroblastoma by in situ hybridization.

Authors:  K J McKenzie; R K Ferrier; A G Howatson; G B Lindop
Journal:  J Pathol       Date:  1996-09       Impact factor: 7.996

5.  The site of inhibin production in ovarian neoplasms.

Authors:  P Flemming; W Grothe; H Maschek; K U Petry; A Wellmann; A Georgii
Journal:  Histopathology       Date:  1996-11       Impact factor: 5.087

6.  Virilizing malignant lipid cell tumor producing erythropoietin.

Authors:  T W Montag; R E Murphy; J L Belinson
Journal:  Gynecol Oncol       Date:  1984-09       Impact factor: 5.482

7.  Autonomous aldosterone-secreting ovarian tumor.

Authors:  J N Kulkarni; R C Mistry; M R Kamat; R Chinoy; R G Lotlikar
Journal:  Gynecol Oncol       Date:  1990-05       Impact factor: 5.482

8.  Ovarian steroid cell tumors associated with Cushing's syndrome: a report of three cases.

Authors:  R H Young; R E Scully
Journal:  Int J Gynecol Pathol       Date:  1987       Impact factor: 2.762

  8 in total
  3 in total

1.  Paraneoplastic erythrocytosis in a malignant ovarian steroid cell tumour.

Authors:  Rimpy Tandon; Poonam Goel; Shailja Kataria; Pradip Kumar Saha; R P S Punia; Kislay Dimri
Journal:  Indian J Hematol Blood Transfus       Date:  2012-09-18       Impact factor: 0.900

2.  Androgen-producing steroid cell ovarian tumor in a young woman and subsequent spontaneous pregnancy.

Authors:  Lauren Sielert; Cheng Liu; Rajeswari Nagarathinam; Latasha B Craig
Journal:  J Assist Reprod Genet       Date:  2013-07-19       Impact factor: 3.412

3.  Occult leydig cell tumour and androgen-receptor positive breast cancer in a woman with severe hyperandrogenism.

Authors:  Giovanna Saraceno; Valeria Barresi; Francesco Trimarchi; Salvatore Cannavo
Journal:  J Ovarian Res       Date:  2013-07-01       Impact factor: 4.234

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.